We are live on ! Find out more
TOIIW

The Oncology Institute Warrant

Delisted

TOIIW was delisted on the 31st of July, 2026.

13 hedge funds and large institutions have $2.77M invested in The Oncology Institute Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

8% more funds holding

Funds holding: 1213 (+1)

0.81% more ownership

Funds ownership: 4.79%5.6% (+0.81%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

62% less capital invested

Capital invested by funds: $7.36M → $2.77M (-$4.59M)

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
2
Closed
1
Calls
$17K
Puts
Net Calls
+$17K
Net Calls Change
-$363K

TOIIW Hedge Fund Activity: Q4 2022 in Review

13 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q4 2022, worth a combined $2.77M — down 62% from $7.36M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TOIIW positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Walleye Capital, opening a new position worth an estimated $116K. The largest seller was Union Square Park Capital Management, exiting entirely with an estimated $66K sold.

  • 13 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q4 2022, up from 12 in Q3 2022.
  • Funds reported $2.77M of The Oncology Institute Warrant stock for Q4 2022, down 62% quarter-over-quarter.
  • 3 funds opened new The Oncology Institute Warrant positions in Q4 2022 and 1 closed out, a net change of +2 holders.
  • The largest The Oncology Institute Warrant buyer in Q4 2022 was Walleye Capital, an estimated $116K added.
  • The largest The Oncology Institute Warrant seller in Q4 2022 was Union Square Park Capital Management, an estimated $66K sold.

Based on aggregated 13F filings for Q4 2022.